News

Our Study Site was invited to participate in clinical trials conducted by the pharmaceutical company Bayer: new treatment of neurogenic bladder

The approval from the sponsor Astellas Pharma, Japan, was received for the Site's participation in a randomized, double-blind, placebo-controlled 24-week phase 3b study to study a new medicine for the elimination of moderate and severe vasomotor symptoms (hot flashes) in postmenopausal women for whom hormone replacement therapy is unacceptable.

Successfully passed the visit of the selection center to participate in three clinical trials for the treatment of ulcerative colitis, sponsored by the pharmaceutical company Pfizer

Successfully passed the visit of the selection center to participate in the clinical trial for the treatment of systemic lupus erythematosus, the sponsor of the study is the pharmaceutical company Biogen